A

Anavex Life Sciences Corp
D

AVXL

10.230
USD
0.23
(2.30%)
Market Closed
Volume
51,651
EPS
-1
Div Yield
-
P/E
-20
Market Cap
867,662,739
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    4.27
    (1.56%)
    277.86 USD
    BIIB
    BIIB
    0.940
    (0.66%)
    143.690 USD
    GILD
    GILD
    -0.110
    (-0.12%)
    92.910 USD
    I
    INCY
    0.120
    (0.17%)
    72.540 USD
    LLY
    LLY
    12.69
    (1.68%)
    766.55 USD
    MRK
    MRK
    0.950
    (0.99%)
    96.620 USD
    P
    PBYI
    0.06500
    (2.20%)
    3.02000 USD
    PFE
    PFE
    0.410
    (1.58%)
    26.425 USD
    REGN
    REGN
    14.51
    (2.13%)
    694.36 USD
    S
    SAGE
    -0.02000
    (-0.28%)
    7.00500 USD
    More
News

Title: Anavex Life Sciences Corp

Sector: Healthcare
Industry: Biotechnology
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.